Studies in the pharmacodynamics of mechlorethamine and AB 100.
作者信息
AUSMAN R K, CREVAR G E, HAGEDORN H, BARDOS T J, AMBRUS J L
出版信息
JAMA. 1961 Nov 18;178:735-8. doi: 10.1001/jama.1961.73040460013007e.
Abstract
摘要
相似文献
1
Studies in the pharmacodynamics of mechlorethamine and AB 100.
JAMA. 1961 Nov 18;178:735-8. doi: 10.1001/jama.1961.73040460013007e.
2
Resistance and cross-resistance of Escherichia coli mutants to anticancer agents: nitrogen mustard and nitromin.
Radiat Res. 1961 Sep;15:290-7.
3
Effects of nitrogen mustard on the liver, administered by the isolated perfusion technique.
Surg Forum. 1961;12:127-8.
4
A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
Cancer Chemother Rep. 1962 Feb;16:417-9.
5
[Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
Haematol Lat. 1961 Oct-Dec;4:411-22.
6
Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
Cancer Chemother Rep. 1962 Feb;16:247-50.
7
[On the antineoplastic properties of N,N-bis-(beta-chloroethyl)-lysine derivatives ("lysepsin")].
Vopr Onkol. 1961;7(11):75-9.
8
[On changes in the iron level and serum protein fractions after cytostatic therapy with N-oxide mustard gas and a nitrogen mustard phosphamide ester].
Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1961;297:128-38.
9
The effect of anticancer agents on nervous tissue.
Cancer Chemother Rep. 1962 Feb;16:543-4.
10
Early clinical trials with anticancer agents; phase I and phase II studies. A. Dosage schedules and routes of administration.
Cancer Chemother Rep. 1962 Feb;16:61-7.
Zotero 插件